Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study.
- Published In:
- Obesity pillars, 7, 100080 (2023)
- Authors:
- Richards, Jesse, Bang, Neha, Ratliff, Erin L, Paszkowiak, Maria A, Khorgami, Zhamak, Khalsa, Sahib S, Simmons, W Kyle
- Database ID:
- RPEP-07319
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07319APA
Richards, Jesse; Bang, Neha; Ratliff, Erin L; Paszkowiak, Maria A; Khorgami, Zhamak; Khalsa, Sahib S; Simmons, W Kyle. (2023). Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study.. Obesity pillars, 7, 100080. https://doi.org/10.1016/j.obpill.2023.100080
MLA
Richards, Jesse, et al. "Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study.." Obesity pillars, 2023. https://doi.org/10.1016/j.obpill.2023.100080
RethinkPeptides
RethinkPeptides Research Database. "Successful treatment of binge eating disorder with the GLP-1..." RPEP-07319. Retrieved from https://rethinkpeptides.com/research/richards-2023-successful-treatment-of-binge
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.